Home > Boards > US OTC > Medical - Healthcare > Progressive Care, Inc. (RXMD)

RXMD NEWS Record 20 Million Sales in 2017

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Davis_Elite Member Profile
Followed By 33
Posts 2,627
Boards Moderated 4
Alias Born 01/16/16
160x600 placeholder
Progressive Care to Present at The Wall Street Investor Forum 26th Annual Investor Conference InvestorsHub NewsWire - 3/16/2018 1:56:39 PM
Progressive Care Reports 18% Increase in Year over Year Prescriptions Filled During February 2018 InvestorsHub NewsWire - 3/16/2018 1:51:59 PM
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share InvestorsHub NewsWire - 3/9/2018 9:25:14 AM
StereoVision (SVSN) $420 million in Sales from $1,000 Acre Hemp Farm Lease InvestorsHub NewsWire - 3/6/2018 6:47:36 AM
Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County InvestorsHub NewsWire - 3/2/2018 9:40:34 AM
Progressive Care to Accept Bitcoin for its Pharmacy Unit InvestorsHub NewsWire - 2/15/2018 10:27:52 AM
Vita Mobile (OTC Pink: VMSI) Develops Artificial Intelligence to work with Facebook, Twitter and Instagram InvestorsHub NewsWire - 2/15/2018 7:00:45 AM
Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018 InvestorsHub NewsWire - 2/13/2018 9:03:01 AM
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions InvestorsHub NewsWire - 1/25/2018 8:00:00 AM
Progressive Care Ends Agreement with Boustead Securities InvestorsHub NewsWire - 1/23/2018 11:17:39 AM
Progressive Care Releases Open Letter to Shareholders InvestorsHub NewsWire - 1/16/2018 11:54:30 AM
Progressive Care Continues to Break Records with Over $20 Million in Sales InvestorsHub NewsWire - 1/10/2018 12:11:11 PM
Progressive Care Reports Strong November Sales to Begin End of Year Rally InvestorsHub NewsWire - 12/15/2017 9:48:16 AM
Progressive Care Announces Uplist to OTCQB InvestorsHub NewsWire - 12/4/2017 11:16:25 AM
ANCE - RESTANCE Highlights Hugh Hefner and Playboy's Contribution To Fighting AIDS and Advocating Gay Rights InvestorsHub NewsWire - 12/1/2017 11:52:28 AM
Progressive Care Reports Stellar Third Quarter Results InvestorsHub NewsWire - 11/15/2017 8:30:00 AM
Progressive Care Announces Third Quarter Conference Call and Webcast with Investors on November 14, 2017 InvestorsHub NewsWire - 11/13/2017 9:34:28 AM
Progressive Care Pays Down Chicago Venture Partners Note in Second Installment InvestorsHub NewsWire - 10/26/2017 10:40:37 AM
Progressive Care Reports $1.5 Million Revenues on 17,000 Prescriptions in September InvestorsHub NewsWire - 10/13/2017 9:34:27 AM
Progressive Care Submits Application for OTCQB Listing InvestorsHub NewsWire - 10/5/2017 8:30:00 AM
Progressive Care Appoints Oleg Firer as an Independent Board Member MIAMI, FL (Marketwired September 25 2017) - Progressive InvestorsHub NewsWire - 9/25/2017 9:16:38 AM
Progressive Care Reports $1.8 Million Revenues on 20,000 Prescriptions in August InvestorsHub NewsWire - 9/19/2017 8:30:00 AM
Progressive Care Is Open Following Hurricane Irma MIAMI InvestorsHub NewsWire - 9/12/2017 12:03:50 PM
Davis_Elite   Thursday, 02/01/18 08:41:06 AM
Re: TheSerb post# 67910
Post # of 78227 
RXMD NEWS Record 20 Million Sales in 2017

PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD) (the “company”), a healthcare services and technology company, today announced, the release of CEO, Shital Mars’ interview on Uptick Newswire Stock Day with Everett Jolly.

Through its operating subsidiaries, Smart Medical Alliance, Inc. and PharmCo, LLC, Progressive Care Inc. is changing the way pharmacies communicate with providers and interact with users. The company’s four pillars; expertise in health care, patient care, pharmaceutical management and customer service have allowed Progressive Care Inc. to thrive and reach a record $20 million in sales in 2017.

“I have been looking forward to having you back on the show,” said Jolly. “Since last we spoke, the stock has increased by more than 100% and you have transferred from pink slip to OTCQB. As a company, you have achieved clarity and efficiencies in an industry that is very difficult to navigate.”

“We are pleased with our year-over-year revenue increases, which have validated our growth strategy and provided the necessary financial platform to focus on research and development,”
commented S. Parikh Mars. “We have also put in place new strategies to increase visibility and distribution in the marketplace, which we expect will support company evolution.”

To listen to the full interview please click here to the following link:

About Progressive Care
Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.

Sign up for our updates:
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the company evolution and growth, financial strength for research and development. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist